AI assistant
Sending…
VALIRX PLC — AGM Information 2013
Apr 22, 2013
7998_dva_2013-04-22_e382e3a0-e44a-4a46-a39a-dd86e6810145.html
AGM Information
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9006C
ValiRx PLC
22 April 2013
ValiRx plc
("ValiRx" or the "Company")
Result of AGM
ValiRx (AIM: VAL), a life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.
Enquiries:
| ValiRx plc Dr Satu Vainikka |
Tel: +44 (0)20 3008 4416 www.ValiRx.com |
| Cairn Financial Advisers LLP (Nominated Adviser) Liam Murray / Avi Robinson |
Tel: +44 (0)20 7148 7900 |
| Hybridan LLP (Broker) Claire Noyce/Deepak Reddy |
Tel: + 44 (0)20 7947 4350 |
| Peckwater PT Tarquin Edwards |
Tel: +44 (0)7879 458 364 [email protected] |
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSESFSEFDSEIL
More from VALIRX PLC
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 2
Share Issue/Capital Change
2026
Jan 19
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 9
Regulatory Filings
2026
Jan 8
Major Shareholding Notification
2025
Dec 5